retatrutide peptide vs tirzepatide 🧬 SEMAGLUTIDE vs 🧬 Understanding the difference could help you make more informed decisions about weight management and metabolic health. 👇 🔹 Semaglutide Targets GLP-1 receptors to help reduce Product page for Retatrutide /

The FDA has approved Contrave for long-term weight management in adults who meet specific BMI requirements: A body mass index (BMI) of 30 kg/m or higher (obese), or A BMI of 27 kg/m or higher (overweight), plus at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol (dyslipidemia) Contrave is an ideal option for: Adults looking for mild to moderate weight loss People who also have depression or binge eating disorder, Contrave may help with mood and cravings Those who prefer taking a daily pill instead of weekly injections Only approved for use in adults (18 and older) If you prefer tablets over injections or do not require significant weight loss (above 10%), Contrave may be right for you

clinicians are directed to consult individual SmPC documents for guidance on use in renal impairment

This was a game changer

Most programs include an initial health screening and ongoing monitoring throughout treatment